From Pandemic to Endemic: the Ethics of Vaccine Sale Profits
Lower middle-income countries would be scratching their heads with the announcement by Great Britain’s biggest pharmaceutical firm AstraZeneca, that it expects to move away from selling its COVID-19 vaccine Vaxzevria at cost price to a scheme where a modest profit is made. According to the company’s Chief Executive Pascal Soriot, they will offer affordable and […]
From Pandemic to Endemic: the Ethics of Vaccine Sale Profits
*Photo credit: ABC News Lower middle-income countries would be scratching their heads with the announcement by Great Britain’s biggest pharmaceutical firm AstraZeneca, that it expects to move away from selling its COVID-19 vaccine Vaxzevria at cost price to a scheme where a modest profit is made. According to the company’s Chief Executive Pascal Soriot, they […]
